Promoter Jay Bhanushali buys 1,424 Aspira Pathlab shares via open market

Promoter Stake BuyOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹130.00

prior close

₹124.01

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+6.6% vs market

Healthcare Service Provider peers, median of 27sector+0.0%+5.0% vs sector

On the reaction day the stock moved 6.6 pts more than Nifty Microcap 250 and 5.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0-1.6+6.6+0.0+5.0

Next day

+10.3-0.6+10.8-1.1+11.3

+11.5-0.8+12.4-0.8+12.3

+1.0-2.1+3.1-2.8+3.7

-3.8-2.1-1.7-3.6-0.1

-8.3-0.8-7.5-3.5-4.9

-13.5-3.8-9.7-4.8-8.7

15d

-7.2-6.9-0.3-6.1-1.1

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jay Arvind Bhanushali, a promoter of Aspira Pathlab and Diagnostics, acquired 1,424 equity shares (about 0.01 percent) through open market purchases between September 17 and September 24, 2026. His holding rose from 7.27 percent to 7.28 percent, taking his total to 7,49,262 shares. Filed under SEBI SAST Regulation 29(2).

Likely market impact

Tiny incremental promoter buy that signals mild confidence, but the change in ownership is negligible and unlikely to move the stock.